The Chemokine MIG is Associated with an Increased Risk of COVID-19 Mortality in Mexican Patients.

Luis Antonio Ochoa-Ramirez Rosalio Ramos Payán German Reynaldo Jimenez-Gastelum Jose Rodriguez-Millan Elsa Maribel Aguilar Juan Jose Rios-Tostado Alfredo Ayala-Ham Mercedes Bermudez Cortez Juan Fidel Osuna-Ramos Vicente Olimón-Andalón Jesús Salvador Velarde-Felix

Published in: Iranian journal of immunology : IJI (2022)

Our results suggest that the increased levels of MCP-1, IP-10, and especially MIG might be useful in predicting severe COVID-19 outcomes and could be promising therapeutic targets.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
early onset
cardiovascular disease
metabolic syndrome
respiratory syndrome coronavirus
patient reported outcomes
insulin resistance